Amgen against Novartis AG — live side-by-side technical comparison.
Prices as of 2026-11-11T14:40:26+00:00 UTC · updates daily
AMGN leads 6 of the 7 windows we measure — over 1 month AMGN is +12.1% and NVS +10.8%; over year to date AMGN is +42.1% and NVS +15.6%. The AMGN/NVS price ratio stands at 2.8889, above its 50-day average of 2.8426, and above the 200-day average of 2.4927. A ratio above its own average means AMGN is gaining on NVS; on this reading the recent edge belongs to AMGN.
Compare AMGN and NVS: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| AMGN | NVS | |
|---|---|---|
| Price | $460.52 | $159.41 |
| 1 day | -1.0%lead | -2.4% |
| 5 days | +0.9%lead | -3.4% |
| 1 month | +12.1%lead | +10.8% |
| 6 months | +40.3%lead | +9.8% |
| Year to date | +42.1%lead | +15.6% |
| 1 year | +36.1%lead | +22.2% |
| 2 years | +43.1% | +50.9%lead |
| 52-week position | 86% of range | 77% of range |
| 52-week range | $312.39–$483.99 | $123.24–$170.46 |
| vs 50-day average | above $424.24 | above $149.21 |
| vs 200-day average | above $379.73 | above $152.44 |
| RSI (14) | 59 | 56 |
| Market cap | $251.6B | — |
| Analyst target | $429.74 (-7.6%) | — |
| Analysts | 29 | — |
| Consensus | Hold | — |
| Next earnings | Feb 2, 2027 | Oct 27, 2026 |
AMGN trades at $460.52, above its 50-day average of $424.24, and above the 200-day at $379.73. It sits at 86% of its 52-week range ($312.39–$483.99); 14-day RSI is 59, in neutral territory; an average session moves it about 2.8%. For levels, the first level overhead is $475.00 (3.1% away) and the first support below is $450.00 (2.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
NVS trades at $159.41, above its 50-day average of $149.21, and above the 200-day at $152.44. It sits at 77% of its 52-week range ($123.24–$170.46); 14-day RSI is 56, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $160.57 (0.7% away) and the first support below is $156.17 (2.0% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
AMGN is the more volatile of the two — an average session moves it 2.8% against 2.4% for NVS, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: AMGN clearing $475.00 or losing $450.00; NVS clearing $160.57 or losing $156.17. Until one of them gives way, the relative reading above stands.